LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| Hs 578T | Canertinib | 0.1727 |
| Hs 578T | Celastrol | 0.5106 |
| Hs 578T | CGP60474 | 1.0771 |
| Hs 578T | CHIR-99021 | 0.0979 |
| Hs 578T | CP466722 | 0.0186 |
| Hs 578T | CP724714 | 0.0578 |
| Hs 578T | Crizotinib | 0.3021 |
| Hs 578T | Momelotinib | 0.3665 |
| Hs 578T | Dasatinib | 0.9309 |
| Hs 578T | Dovitinib | 0.6149 |
| Hs 578T | Enzastaurin | -0.0025 |
| Hs 578T | Erlotinib | 0.0855 |
| Hs 578T | Alvocidib | 1.1122 |
| Hs 578T | Foretinib | 0.5940 |
| Hs 578T | Pictilisib | 0.4653 |
| Hs 578T | GDC-0980 | 0.7122 |
| Hs 578T | Gefitinib | 0.0259 |
| Hs 578T | Geldanamycin | 0.8279 |
| Hs 578T | GSK 690693 | 0.2355 |
| Hs 578T | GSK1059615 | 0.5241 |
| Hs 578T | GSK1904529A | 0.0468 |
| Hs 578T | Omipalisib | 1.0122 |
| Hs 578T | GW843682X | 0.8294 |
| Hs 578T | HG-5-113-01 | 0.4678 |
| Hs 578T | HG-5-88-01 | 0.1381 |